Ralph Snyderman - 27 May 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Peter Maag as attorney-in-fact for Ralph Snyderman
Issuer symbol
CDNA
Transactions as of
27 May 2021
Net transactions value
-$761,849
Form type
4
Filing time
10 Jun 2021, 17:32:12 UTC
Next filing
21 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Sale $159,266 -1,966 -3.2% $81.01* 58,549 27 May 2021 Direct F1
transaction CDNA Common Stock Sale $203,595 -2,511 -4.3% $81.08* 56,038 28 May 2021 Direct F2
transaction CDNA Common Stock Sale $194,173 -2,512 -4.5% $77.30* 53,526 01 Jun 2021 Direct F3
transaction CDNA Common Stock Sale $204,815 -2,511 -4.7% $81.57* 51,015 02 Jun 2021 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.94 to $81.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.01 to $81.18, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.28 to $77.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.43 to $81.71, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.